{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:08:41Z","timestamp":1789142921484,"version":"build-2803163510"},"reference-count":65,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"abstract":"<jats:p>Background: Treatment inertia, non-adherence and non-persistence to medical treatment contribute to poor blood pressure (BP) control worldwide. Fixed dose combination (FDC) antihypertensive medicines simplify prescribing patterns and improve adherence. The aim of this study was to identify factors associated with prescribing FDC antihypertensive medicines and to understand if these factors differ among doctors worldwide.\nMethods: A cross-sectional survey was conducted online from June 2023 to January 2024 to recruit doctors. We collaborated with an international network of researchers and clinicians identified through institutional connections. A passive snowballing recruitment strategy was employed, where network members forwarded the survey link to their clinical colleagues. The survey instrument, developed through a literature review, interviews with academic and clinical researchers, and pilot testing, assessed participants perspectives on prescribing FDC antihypertensive medicines for hypertension. Participants rated their level of agreement (5-point Likert scale) with statements representing six barriers and four facilitators to FDC use.\nFindings: Data from 191 surveys were available for analysis. 25% (n = 47) of participants worked in high-income countries, 38% (n = 73) in upper-middle income, 25% (n = 48) in lower-middle income, 6% (n = 10) in low-income countries. Forty percent (n = 70) of participants were between 36\u201345 years of age; two thirds were male. Cost was reported as a barrier to prescribing FDC antihypertensive medicines [51% (n = 87) agreeing or strongly agreeing], followed by doctors\u2019 confidence in BP measured in clinic [40%, (n = 70)], access [37%, (n = 67)], appointment duration [35%, (n = 61)], concerns about side-effects [(21%, n = 37)], and non-adherence [12%, (n = 21)]. Facilitators to FDC antihypertensive polypills prescribing were clinician facing, such as access to educational supports [79%, (n = 143)], more BP measurement data [67%, (n = 120)], a clinical nudge in health records [61%, (n = 109)] and patient-facing including improved patient health literacy [49%, (n = 88)]. The levels of agreement and strong agreement across all barriers and facilitators were similar for participants working in higher or lower income countries. Across all countries, participants rated FDC antihypertensive medications highly valuable for managing patients with non-adherence, (82% reported high or very high value), for patients with high pill burden (80%).\nInterpretation: Cost and access were the most common barriers to prescribing FDCs across high- and low-income countries. While greater educational support for clinicians was perceived as the leading potential facilitator of FDC use, this seems unlikely to be effective without addressing access.<\/jats:p>","DOI":"10.5334\/gh.1353","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:51:51Z","timestamp":1726138311000},"page":"73","source":"Crossref","is-referenced-by-count":16,"title":["A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative Insights"],"prefix":"10.5334","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1914-5918","authenticated-orcid":false,"given":"Edel","family":"O\u2019Hagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-4050","authenticated-orcid":false,"given":"Daniel","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-8920","authenticated-orcid":false,"given":"Tu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-3109","authenticated-orcid":false,"given":"Kit Mun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-3934","authenticated-orcid":false,"given":"Peter","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-4128","authenticated-orcid":false,"given":"Dzudie","family":"Anastase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-9237","authenticated-orcid":false,"given":"Toon Wei","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-7510","authenticated-orcid":false,"given":"Anezi","family":"Uzendu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-6000","authenticated-orcid":false,"given":"Tan","family":"Van Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6448-5375","authenticated-orcid":false,"given":"Wei Jin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4066-0738","authenticated-orcid":false,"given":"Hui Min","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-0345","authenticated-orcid":false,"given":"Timothy","family":"Usherwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-0038","authenticated-orcid":false,"given":"Clara K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"4","key":"key20240912065114_B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"10304","key":"key20240912065114_B2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"The Lancet"},{"issue":"9","key":"key20240912065114_B3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20240912065114_B4","unstructured":"Schutte A, Srinivasapura Venkateshmurthy N, Mohan S, Prabakaran D. Hypertension in low- and middle-income countries [Internet]. [cited 2022 Nov 14]. Available from: https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/CIRCRESAHA.120.318729."},{"issue":"4","key":"key20240912065114_B5","article-title":"Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: therapeutic inertia and treatment simplification. The SIMPLIFY study","volume":"16","year":"2021","journal-title":"PLoS ONE"},{"key":"key20240912065114_B6","article-title":"Combination therapy in the treatment of hypertension","volume":"7","year":"2018","journal-title":"Drugs Context"},{"issue":"25","key":"key20240912065114_B7","doi-asserted-by":"crossref","first-page":"e11121","DOI":"10.1097\/MD.0000000000011121","article-title":"Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis","volume":"97","year":"2018","journal-title":"Med Baltim"},{"issue":"5","key":"key20240912065114_B8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/HJH.0000000000000118","article-title":"Evolution of therapy inertia in primary care setting in Spain during 2002\u20132010","volume":"32","year":"2014","journal-title":"J Hypertens"},{"issue":"9","key":"key20240912065114_B9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ajh\/hpab054","article-title":"Patient awareness and clinical inertia: obstacles to hypertension control in rural communities in the Dominican Republic","volume":"34","year":"2021","journal-title":"Am J Hypertens"},{"issue":"5","key":"key20240912065114_B10","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"key20240912065114_B11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.13272","article-title":"The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis","volume":"20","year":"2018","journal-title":"J Clin Hypertens"},{"issue":"7","key":"key20240912065114_B12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in Hypertension","volume":"124","year":"2019","journal-title":"Circulation Research"},{"issue":"38","key":"key20240912065114_B13","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key20240912065114_B14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2021.01.070","article-title":"Current challenges for hypertension management: from better hypertension diagnosis to improved patients\u2019 adherence and blood pressure control","volume":"331","year":"2021","journal-title":"Int J Cardiol"},{"issue":"11","key":"key20240912065114_B15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamacardio.2020.2739","article-title":"Association of low-dose triple combination therapy with therapeutic inertia and prescribing patterns in patients with hypertension","volume":"5","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"key20240912065114_B16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"17","key":"key20240912065114_B17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/heartjnl-2022-321496","article-title":"Hypertension therapy using fixed-dose polypills that contain at least three medications","volume":"109","year":"2023","journal-title":"Heart"},{"issue":"5","key":"key20240912065114_B18","first-page":"1087","article-title":"Therapeutic inertia in people receiving initial ultra low-quadruple dose combination therapy and standard dose monotherapy: results from the QUARTET trial","volume":"81","year":"2024","journal-title":"Hypertension"},{"issue":"19","key":"key20240912065114_B19","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"key20240912065114_B20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"1","key":"key20240912065114_B21","first-page":"4","article-title":"Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: clinical perspective and policy implications","volume":"21","year":"2018","journal-title":"J Clin Hypertens"},{"issue":"4","key":"key20240912065114_B22","first-page":"973","article-title":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005\u20132016","volume":"75","year":"2020","journal-title":"Hypertens Dallas Tex 1979"},{"issue":"10","key":"key20240912065114_B23","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/jch.14009","article-title":"Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: an overview of efficacy, safety, and cost","volume":"22","year":"2020","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"key20240912065114_B24","unstructured":"World Bank Country and Lending Groups \u2013 World Bank Data Help Desk [Internet]. [cited 2024 Jan 15]. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups."},{"key":"key20240912065114_B25","unstructured":"OSF: POPPI-Perspectives on Polypill Prescribing Internationally [Internet]. [cited 2024 Jan 15]. Available from: https:\/\/osf.io\/nbypu\/."},{"key":"key20240912065114_B26","unstructured":"Qualtrics Survey: Qualtrics Experience Management [Internet]. [cited 2023 Jan 24]. Available from: https:\/\/sydney.au1.qualtrics.com\/jfe\/form\/SV_d4JbtBbNqOuBndY."},{"issue":"3","key":"key20240912065114_B27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/jhh.2008.117","article-title":"Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries","volume":"23","author":"the National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial","year":"2009","journal-title":"J Hum Hypertens"},{"issue":"21","key":"key20240912065114_B28","article-title":"Disparities in prevalence and barriers to hypertension control: a systematic review","volume":"19","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"key20240912065114_B29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"key20240912065114_B30","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"key20240912065114_B31","first-page":"e190","article-title":"Barriers to and enablers of advance care planning with patients in primary care","volume":"64","year":"2018","journal-title":"Can Fam Physician"},{"issue":"2","key":"key20240912065114_B32","article-title":"Recruiting general practitioners for surveys: reflections on the difficulties and some lessons learned","volume":"21","year":"2015","journal-title":"Aust J Prim Health"},{"issue":"6","key":"key20240912065114_B33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/nur.21976","article-title":"Conducting surveys with multidisciplinary health care providers: current challenges and creative approaches to sampling, recruitment, and data collection","volume":"42","year":"2019","journal-title":"Res Nurs Health"},{"issue":"3","key":"key20240912065114_B34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/01632787211019445","article-title":"Remind me again: physician response to web surveys: the effect of email reminders across 11 opinion survey efforts at the American Board of Internal Medicine from 2017 to 2019","volume":"44","year":"2021","journal-title":"Eval Health Prof"},{"issue":"2","key":"key20240912065114_B35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2648.2004.03185.x","article-title":"Instrument translation process: a methods review","volume":"48","year":"2004","journal-title":"J Adv Nurs"},{"key":"key20240912065114_B36","unstructured":"Walli-Attaei M, Joseph P, Johansson I, Sliwa K, Lonn E, Maggioni AP, et al. Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry. Lancet Glob Health [Internet]. 2024 Jan 10 [cited 2024 Jan 15]. Available from: https:\/\/www.thelancet.com\/journals\/langlo\/article\/PIIS2214-109X(23)00557-0\/fulltext."},{"key":"key20240912065114_B37","unstructured":"R: The R Project for Statistical Computing [Internet]. [cited 2022 Oct 14]. Available from: https:\/\/www.r-project.org\/."},{"issue":"11","key":"key20240912065114_B38","article-title":"Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries","volume":"5","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"9","key":"key20240912065114_B39","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(17)30141-X","article-title":"Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"2","year":"2017","journal-title":"Lancet Public Health"},{"issue":"10","key":"key20240912065114_B40","doi-asserted-by":"crossref","first-page":"e1359","DOI":"10.1016\/S2214-109X(19)30343-2","article-title":"Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial","volume":"7","year":"2019","journal-title":"Lancet Glob Health"},{"key":"key20240912065114_B41","article-title":"Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure","year":"2023","journal-title":"Heart"},{"issue":"7","key":"key20240912065114_B42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.hlc.2022.01.010","article-title":"Are we there yet? Exploring the use of single-pill combination therapy in the management of raised blood pressure in Australia","volume":"31","year":"2022","journal-title":"Heart Lung Circ"},{"issue":"5","key":"key20240912065114_B43","article-title":"Cost-related medication nonadherence and desire for medication cost information among adults aged 65 years and older in the US in 2022","volume":"6","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"key20240912065114_B44","article-title":"Physician awareness of drug cost: a systematic review","volume":"4","year":"2007","journal-title":"PLoS Med"},{"key":"key20240912065114_B45","article-title":"Clinical inertia and outpatient medical errors","volume":"2","journal-title":"Clin Inertia"},{"issue":"10","key":"key20240912065114_B46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2519\/jospt.2021.0203","article-title":"The therapeutic alliance may yet prove effective","volume":"51","year":"2021","journal-title":"J Orthop Sports Phys Ther"},{"key":"key20240912065114_B47","article-title":"What do people post on social media relative to low back pain? A content analysis of Australian data","volume":"54","year":"2021","journal-title":"Musculoskelet Sci Pract"},{"issue":"9","key":"key20240912065114_B48","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/HJH.0000000000002922","article-title":"Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension","volume":"39","year":"2021","journal-title":"J Hypertens"},{"key":"key20240912065114_B49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41569-022-00690-0","article-title":"Blood pressure and its variability: classic and novel measurement techniques","volume":"19","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"key20240912065114_B50","article-title":"Implementing a digital intervention for managing uncontrolled hypertension in Primary Care: a mixed methods process evaluation","volume":"16","year":"2021","journal-title":"Implement Sci"},{"issue":"5","key":"key20240912065114_B51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1751-7176.2012.00607.x","article-title":"Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial","volume":"14","year":"2012","journal-title":"J Clin Hypertens"},{"key":"key20240912065114_B52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2023.11.005","article-title":"Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial","volume":"268","year":"2024","journal-title":"Am Heart J"},{"issue":"5","key":"key20240912065114_B53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cjca.2020.12.004","article-title":"WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada","volume":"37","year":"2021","journal-title":"Can J Cardiol"},{"key":"key20240912065114_B54","article-title":"The HEARTS partner forum\u2014supporting implementation of HEARTS to treat and control hypertension","volume":"11","year":"2023","journal-title":"Front Public Health"},{"issue":"11","key":"key20240912065114_B55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41371-022-00675-z","article-title":"Wearable blood pressure measurement devices and new approaches in hypertension management: the digital era","volume":"36","year":"2022","journal-title":"J Hum Hypertens"},{"issue":"2","key":"key20240912065114_B56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jash.2014.12.001","article-title":"A content analysis of smartphone\u2013based applications for hypertension management","volume":"9","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"key20240912065114_B57","article-title":"Smartphone applications for hypertension management: a potential game-changer that needs more control","volume":"19","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"key20240912065114_B58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/HYPERTENSIONAHA.119.13273","article-title":"Interactive mobile health intervention and blood pressure management in adults","volume":"74","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"key20240912065114_B59","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1185\/03007995.2015.1098598","article-title":"Comparison of amlodipine\/valsartan\/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs","volume":"31","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"key20240912065114_B60","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1185\/03007995.2014.964853","article-title":"A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy","volume":"30","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"key20240912065114_B61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jash.2012.11.001","article-title":"Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients","volume":"7","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"key20240912065114_B62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/PPA.S150142","article-title":"Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts","volume":"12","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"key20240912065114_B63","first-page":"e128","article-title":"The potential for a chat-based artificial intelligence model to facilitate educational messaging on hypertension","volume":"80","year":"2023","journal-title":"Hypertension"},{"issue":"5","key":"key20240912065114_B64","article-title":"Patients\u2019 and health professionals\u2019 attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies","volume":"4","year":"2020","journal-title":"BJGP Open"},{"issue":"3","key":"key20240912065114_B65","article-title":"Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study","volume":"3","year":"2013","journal-title":"BMJ Open"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1353\/1764","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1353\/1765","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1353\/1766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/download\/1353\/1764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:59:38Z","timestamp":1726138778000},"score":1,"resource":{"primary":{"URL":"https:\/\/account.globalheartjournal.com\/index.php\/up-j-gh\/article\/view\/1353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,8]]}},"URL":"https:\/\/doi.org\/10.5334\/gh.1353","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}